Philip Bredin

Cancer care’s climate cost is rising. 🌎 Dr. Emer Lynch & team, with OUCH’s Dr. Seamus O'Reilly as senior author, outlines key steps forward in @JCO_ASCO.  Editorial by Dr. Peppercorn calls for urgent action. Read: doi.org/10.1200/OP-24-… Editorial: doi.org/10.1200/OP-25-…

🤔 Should We Talk About the Weather ? ascopubs.org/doi/10.1200/OP… . Thank you @EthicsdoctorP for the eloquent @JCOOP_ASCO editorial ☝️ about reconciling care for 🤕versus care for 🌎 as discussed in our 🇮🇪🇳🇱 ✍️ ascopubs.org/doi/10.1200/OP… - Clinicmaps for ♻️ Care 👇

📣Multidisciplinary Solution Focused Webinar helpful suggestions for ♻️ Practice 🏥🩻🩺⚕️💊🚑 👇 @OUCH_OncsUnited @joan_schiller @BeckiLee @IrishDocsEnv @RCSI_Irl @LichterKatie @DrShelleyHwang @CathWeadick @haileykcarroll @aislingbarryro @PhilipBredin

Thank you for this insightful discussion of @CUH_Cork @CanResUCC @cancertrials_ie 🌷☘️📃@JCOOP_ASCO on what oncologists can do today for #climatechange . Infographics 👇 Tx to ✍️incl. @PhilipBredin @CathWeadick @niamhdorney 💪 Latest 📃 doi.org/10.1016/j.clbc… @IrishDocsEnv

Sustainability Tool Kit for Medical Oncologists 👇 Translated 🇪🇸🇮🇹🇸🇪🇩🇪🇵🇹🇫🇷🇳🇱 versions in suppl. ✍️led by Dr Emer Lynch @PhilipBredin Why We Should, and How We Can, Reduce the Climate Toxicity of Cancer Care ascopubs.org/doi/10.1200/OP…

Privileged to work with my co-first author Dr Emer Lynch, and inspirational mentor Prof @Seamusoreilly18, co-authors Drs @CathWeadick @niamhdorney and Roelof Van Leeuwen on this essential commentary

Why We Should, and How We Can, Reduce the Climate Toxicity of Cancer Care doi.org/10.1200/OP-24-…

Loss of KMT2C can drive endocrine resistance in breast ca by altering the epigenomic landscape and uncoupling Erα-driven proliferation from oestrogen

Delighted to contribute to this in-depth summary of KMT2C and KMT2D aberrations in breast oncogenesis by @emily_tinno authors.elsevier.com/c/1ijCJ8Z12yXi… Driver mutations in KMT2C/D are in top 5 – 10 most common in all solid cancer but clinical significance remains poorly understood

@RCSI_StAR_MD @sinead_toomey

KMT2C/D COMPASS complexes contribute to selective enhancer activation promoting cell differentiation Known tumour suppressors in breast ca, context-specific dual roles of KMT2C/D in oncogenesis demonstrate complexity of topic

Our final group of StAR MD students for today gave us updates on the first 6 month of their translational research projects in urology, hematology, endocrinology and oncology. Amazing progress made by everyone in such a short time!

Great to see poster presentations from some of our StAR MD students at todays @CancerCentreIre meeting. Pictured at their posters are Dr Gavin Dowling and Dr @PhilipBredin

Congratulations @PhilipBredin on getting this excellent review published!

Check out this comprehensive review on gut microbial determinants of response & toxicity to immune checkpoint inhibitors for nsclc Led by stellar @RCSI_StAR_MD fellow @PhilipBredin @CancerCentreIre @IrishLungCancer @lcfamerica @OncoAlert #LCSM link.springer.com/article/10.100…

@DrJNaidoo @RCSI_StAR_MD @CancerCentreIre @IrishLungCancer @lcfamerica @OncoAlert Thank you Dr Naidoo!

@Deirdreomahon14 @ndenduluri1 Thank you Dr O’Mahony!

Congratulations @ndenduluri1 @philipbredin and prof janice Walshe on a wonderfully constructed review on #her2 #advancedbreastcancer